Q3 2024 · 13F-HR
Kynam Capital Management, LPholdings as filed
Filed 2024-11-14 · accession 0001085146-24-005812
$1.30B
Reported value
25
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 632307104 | NTRA | NATERA INC | $259.3M | 19.9% | 2,042,471 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $118.8M | 9.10% | 1,039,288 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $117.6M | 9.01% | 3,458,609 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $112.5M | 8.62% | 5,842,925 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $99.8M | 7.65% | 9,239,731 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $92.8M | 7.12% | 8,332,687 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $69.7M | 5.34% | 1,576,549 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $69.0M | 5.29% | 9,085,368 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $66.8M | 5.12% | 1,770,805 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $57.1M | 4.38% | 2,511,295 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $40.2M | 3.08% | 4,899,497 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $31.9M | 2.45% | 1,302,085 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $28.1M | 2.15% | 5,953,825 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $22.7M | 1.74% | 2,266,328 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $20.5M | 1.57% | 456,369 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $19.2M | 1.47% | 1,371,511 | Common | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $15.2M | 1.16% | 3,685,563 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $14.0M | 1.07% | 30,000 | PUT | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $11.5M | 0.88% | 1,736,227 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $11.0M | 0.84% | 467,947 | Common | SOLE |
| 023111206 | — | AMARIN CORP PLC | $7.8M | 0.60% | 12,414,628 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $7.1M | 0.55% | 2,066,447 | Common | SOLE |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $4.6M | 0.35% | 2,356,147 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $4.2M | 0.32% | 847,366 | Common | SOLE |
| 12233L206 | BNR | BURNING ROCK BIOTECH LTD | $3.2M | 0.25% | 989,217 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.